Today's Date
A Phase 2a trial of Teplizumab and RN168 in patients with new onset type 1 diabetes mellitus
(
)
ITN Protocol #:
ITN083AI
Branded Name:
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Withdrawn
Summary:
Loading ...
ITN Protocol #:
ITN083AI
Branded Name:
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Withdrawn
Summary:
Admin Links
Shortcuts
ITN Documents
Links